Atlas Trials

XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)

Clinical trial NCT05579314 · COMPLETED

Trial details

NCT number
NCT05579314
Sponsor
Sciwind Biosciences USA Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2022-09-26
Primary completion
2024-11-16
Enrollment
127

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.